XML 20 R10.htm IDEA: XBRL DOCUMENT
v3.24.1.1.u2

PREPAID EXPENSES AND OTHER CURRENT ASSETS | 3 Months Ended
--- | ---
Mar. 31, 2024
Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Abstract] |
PREPAID EXPENSES AND OTHER CURRENT ASSETS | NOTE 3. PREPAID EXPENSES AND OTHER CURRENT ASSETS As of March 31, 2024 and December 31, 2023, the prepaid expenses and other current assets of the Company consisted of the following: SCHEDULE OF PREPAID EXPENSES AND OTHER CURRENT ASSETS
|  | March 31, 2024 |  |  | December 31, 2023 |
Prepaid research and development |  | $ | 187,701 |  |  | $ | 46,320 |
Prepaid value-added taxes |  |  | 241,577 |  |  |  | 243,429 |
Prepaid insurance |  |  | 509,715 |  |  |  | 149,559 |
Prepaid other |  |  | 82,353 |  |  |  | 62,036 |
Deferred offering costs (see Note 7) |  |  | 395,660 |  |  |  | 567,603 |
Franchise tax receivable |  |  | 58,758 |  |  |  | 79,258 |
R&D tax incentive receivable |  |  | 397,022 |  |  |  | 145,349 |
Total prepaid expenses and other current assets |  | $ | 1,872,786 |  |  | $ | 1,293,554 |
ENVERIC BIOSCIENCES, INC. AND SUBSIDIARIES NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

X
- References No definition available. + Details
Name: | us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for other current assets. + References No definition available. + Details
Name: | us-gaap_OtherCurrentAssetsTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration